Cytek Biosciences (CTKB) executive compensation, 2026 proxy

Wenbin Jiang, Ph.D., Chief Executive Officer and President, was paid $5.1M in 2025, down 16% from $6.1M the year before. The CEO-to-median-employee pay ratio was 33:1, on median employee pay of $157,393.

Filed
April 28, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
5
CEO total pay
$5.1M-16% vs prior year
CEO to median employee
33:1median $157,393
CEO pay in equity
49%$2.5M in awards
Prior say-on-pay support
93%of votes cast
CEO Target Bonus
$620,0002025 cash incentive target
Peer Revenue Range
$100M-$600MUsed for 2025 peer group
Consultant Fees
$83,010Paid to Meridian in 2025

How Ph.D. was paid

$5.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Wenbin Jiang, Ph.D.Chief Executive Officer and President$5,120,061
William McCombeChief Financial Officer$2,460,979
Ming Yan, Ph.D.Chief Technology Officer$1,457,420
Valerie BarnettChief Legal Officer and Corporate Secretary$2,174,943
Philippe Busque, Ph.D.Senior Vice President, Global Sales and Services$1,021,730

What changed and why

  • $5.1MChief Executive Officer total compensation decreased to $5,120,061 in fiscal year 2025 from $6,084,671 in the prior year.
  • Meridian Compensation Partners was engaged as independent compensation consultant to benchmark executive pay against peer companies.
  • 93.1%Stockholders approved the 2025 say-on-pay proposal with over 93.1% of votes cast in favor.
  • Named executive officer compensation included base salaries, stock awards, option awards, and 401(k) matching contributions.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.